Performance CRO

Convert real product microstructure into physics-based digital twins that simulate drug release and manufacturing behavior, supporting smarter early- and late-stage decisions.

Microstructure CQAs
Tablet

Who this is for

Teams that already understand the importance of microstructure and now need to predict performance, reduce risk, and guide development decisions with confidence.

Ideal Timing

Performance CRO is most valuable during early development when material and budget are limited, while narrowing formulation and process options, and when planning scale-up or preparing Q3, NDA/ANDA, or tech-transfer packages, especially when reducing reliance on long, expensive physical experiments is critical.

Business Outcomes

Shorter development loops
Fewer full formulation–release cycles; more targeted experiments based on simulation results.
Reduced scale‑up and tech‑transfer risk
Cut down troubleshooting and rework during scale upand tech transfer.
Enhanced regulatory readiness
We deliver quantitative structure–performance relationships that support Q3, NDA/ANDA, or tech‑transfer documentation.

Scientific Workflow

Provide real product microstructure digital twins, computational representations built from imaging and quantified structure. DigiM predicts drug release and manufacturing scenarios to inform early- and late-stage decisions.

Transform Your Program with Microstructure Science

Get started with a drug product digital twin.